ELIAS JOSEPH JABBOUR to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.031
-
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome. Br J Haematol. 2021 11; 195(3):378-387.
Score: 0.031
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.